Supriya Lifescience Limited (SUPRIYA) — Capital Reinvestment Ratio
Latest as of September 2025:
0.76x
Supriya Lifescience Limited (SUPRIYA) has a Capital Reinvestment Ratio of 0.76x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs555.65 Million) in capital expenditures (Rs422.49 Million). See how much free cash does Supriya Lifescience Limited generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.76x
Capex / Operating Cash Flow
Operating Cash Flow
Rs555.65 Million
INR
Capital Expenditures
Rs422.49 Million
INR
Data as of
Sep 2025
Most recent filing
Supriya Lifescience Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Supriya Lifescience Limited's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Supriya Lifescience Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Supriya Lifescience Limited from 2018 to 2025. For live market cap and broader valuation context, see SUPRIYA market cap.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.94x | Rs1.73 Billion | Rs1.62 Billion | ▼ -26.8% |
| 2024 | 1.29x | Rs1.13 Billion | Rs1.46 Billion | ▼ -21.5% |
| 2023 | 1.64x | Rs661.87 Million | Rs1.08 Billion | ▲ +33.4% |
| 2022 | 1.23x | Rs488.01 Million | Rs599.04 Million | ▲ +103.4% |
| 2021 | 0.60x | Rs799.30 Million | Rs482.41 Million | ▲ +185.6% |
| 2020 | 0.21x | Rs1.16 Billion | Rs245.25 Million | ▲ +48.1% |
| 2019 | 0.14x | Rs486.72 Million | Rs69.45 Million | ▼ -49.5% |
| 2018 | 0.28x | Rs174.52 Million | Rs49.30 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow